UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended		4 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ 3,025,044	$ (1,613,958)	$ (1,636,519)	$ 19,382,427
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Change in the fair value of derivative warrant liabilities	(4,580,630)	533,430	533,430	(21,581,570)
Investment income from the Trust Account	(5,236)	(4,821)	(4,821)	(15,538)
Financing costs - derivative warrant liabilities		959,510	959,510
General and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares			19,800
General and administrative expenses paid by Sponsor under promissory note			11,055
Changes in operating assets and liabilities:
Prepaid expenses			(206,042)	(160,651)
Accounts payable			190,278	62,467
Accrued expenses			4,575	1,381,000
Net cash used in operating activities			(128,734)	(931,865)
Cash Flows from Investing Activities:
Cash deposited in Trust Account			(346,725,000)
Net cash used in investing activities			(346,725,000)
Cash Flows from Financing Activities:
Proceeds from note payable to related party			92,208
Repayment of note payable to related party			(188,213)
Proceeds from working capital loan to related party				30,600
Proceeds received from initial public offering, gross			345,000,000
Proceeds received from private placement			10,625,000
Offering costs paid			(7,105,253)
Net cash provided by financing activities			348,423,742	30,600
Net change in cash			1,570,008	(901,265)
Cash - beginning of the period			0	974,815
Cash - end of the period	$ 73,550	$ 1,570,008	1,570,008	$ 73,550
Supplemental disclosure of noncash investing and financing activities:
Offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares			5,200
Offering costs included in accounts payable			284,443
Offering costs included in accrued expenses			75,000
Offering costs funded with note payable			84,950
Deferred underwriting commissions			12,075,000
Accretion of Class A ordinary shares to redemption			$ 39,025,336